CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Cash Flow Y/Y Annual
Baxter International Inc   (NYSE: BAX)
Other Ticker:  
 
 

BAX's Net Cash Flow Growth by Quarter and Year

Baxter International Inc 's Net Cash Flow results by quarter and year

 



BAX Net Cash Flow (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December - 334.00 -2,594.00 118.00
3rd Quarter September - -16.00 4,066.00 -252.00
2nd Quarter June - -934.00 49.00 -443.00
1st Quarter March -118.00 -168.00 -45.00 -657.00
FY   -118.00 -784.00 1,476.00 -1,234.00

BAXs Annual Net Cash Flow
Baxter International Inc 's Net Cash Flow in the fiscal year 2024 $ -784.00 millions
Baxter International Inc 's Net Cash Flow in the fiscal year 2023 $ 1,476.00 millions
Baxter International Inc 's Net Cash Flow in the fiscal year 2022 $ -1,234.00 millions
Baxter International Inc 's Net Cash Flow in the fiscal year 2021 $ -780.00 millions
Baxter International Inc 's Net Cash Flow in the fiscal year 2020 $ 401.00 millions




BAX Net Cash Flow first quarter 2025 Y/Y Growth Comment
Baxter International Inc in the first quarter 2025 recorded net cash outflow of $ -118.00 millions.

Looking into first quarter 2025 results within Medical Equipment & Supplies industry 12 other companies have achieved higher Net Cash Flow growth. While Baxter International Inc ' s Net Cash Flow no change of 0% ranks overall at the positon no. 284 in the first quarter 2025.


BAX Net Cash Flow ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Baxter International Inc 's first quarter 2025 Net Cash Flow $ -118.00 millions BAX's Income Statement
Baxter International Inc 's first quarter 2024 Net Cash Flow $ -168.00 millions Quarterly BAX's Income Statement


BAX Net Cash Flow (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - 8197.96 % -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Go to BAX Cash flow Statement >> Back to BAX Growth rate Comparisons >>


Net Cash Flow first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #13
Healthcare Sector #41
Overall #284

Net Cash Flow Y/Y Growth Statistics
High Average Low
380.8 % -217.41 % -2913.79 %
(Dec. 29. 2006)   (Sep. 28. 2011)
Net Cash Flow first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #13
Healthcare Sector #41
Overall #284
Net Cash Flow Y/Y Growth Statistics
High Average Low
380.8 % -217.41 % -2913.79 %
(Dec. 29. 2006)   (Sep. 28. 2011)

Net Cash Flow by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Baxter International Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BAX's I. Quarter Q/Q Net Cash Flow Comment
Recent accomplishment of -118.00 millions by Baxter International Inc come out even worse considering the 334.00 millions a quarter before.

Within Medical Equipment & Supplies industry Baxter International Inc achieved highest sequential Net Cash Flow growth. While Baxter International Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BAX's I. Quarter Q/Q Net Cash Flow Comment
Recent accomplishment of -118.00 millions by Baxter International Inc come out even worse considering the 334.00 millions a quarter before.

Within Medical Equipment & Supplies industry Baxter International Inc achieved highest sequential Net Cash Flow growth. While Baxter International Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Baxter International Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)
Cumulative Net Cash Flow 12 Months Ending $ -734.00 $ -784.00 $ -3,712.00 $ 370.00 $ 1,353.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - -72.65 % -8.33 %
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #


Cumulative Net Cash Flow growth Comment
Baxter International Inc realized trailing twelve months net cash outflow of $ -734 millions, in the Mar 31 2025, compare to Net Cash Flow of $ 1,353 millions a year ago.

Baxter International Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 29
Sector # 83
S&P 500 # 569
Cumulative Net Cash Flow growth Comment
Baxter International Inc realized trailing twelve months net cash outflow of $ -734 millions, in the Mar 31 2025, compare to Net Cash Flow of $ 1,353 millions a year ago.

Baxter International Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 29
Sector # 83
S&P 500 # 569




Other Net Cash Flow Growth
Medical Equipment & Supplies Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
BAX's Net Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for BAX's Competitors
Net Cash Flow Growth for Baxter International Inc 's Suppliers
Net Cash Flow Growth for BAX's Customers

You may also want to know
BAX's Annual Growth Rates BAX's Profitability Ratios BAX's Asset Turnover Ratio BAX's Dividend Growth
BAX's Roe BAX's Valuation Ratios BAX's Financial Strength Ratios BAX's Dividend Payout Ratio
BAX's Roa BAX's Inventory Turnover Ratio BAX's Growth Rates BAX's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Mar 31 2025 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2025
Envista Holdings Corporation-3.53%$ -3.529 millions
Nexien Biopharma Inc -6.30%$ -6.297 millions
Pluri Inc-6.84%$ -6.844 millions
Penumbra Inc-7.15%$ -7.151 millions
Regenxbio Inc -7.49%$ -7.489 millions
Sellas Life Sciences Group Inc -8.65%$ -8.650 millions
Viatris Inc -9.42%$ -9.417 millions
Fonar Corporation-10.96%$ -10.964 millions
Nautilus Biotechnology Inc -11.69%$ -11.687 millions
Zentalis Pharmaceuticals Inc -16.18%$ -16.183 millions
Arcus Biosciences Inc -27.59%$ -27.586 millions
Seastar Medical Holding Corporation-28.21%$ -28.206 millions
Contineum Therapeutics Inc -28.59%$ -28.591 millions
Staar Surgical Co-29.35%$ -29.354 millions
Ironwood Pharmaceuticals inc -32.21%$ -32.206 millions
Ani Pharmaceuticals Inc-33.90%$ -33.895 millions
Acurx Pharmaceuticals inc -35.22%$ -35.222 millions
Avenue Therapeutics Inc -35.65%$ -35.648 millions
Cryoport inc -37.53%$ -37.534 millions
Iqvia Holdings Inc -44.12%$ -44.118 millions
Amphastar Pharmaceuticals Inc -45.17%$ -45.168 millions
Seer Inc -46.61%$ -46.609 millions
Serina Therapeutics Inc -47.67%$ -47.669 millions
Scienture Holdings Inc -47.97%$ -47.966 millions
Humacyte Inc -48.91%$ -48.912 millions
Enveric Biosciences Inc -49.52%$ -49.524 millions
Cytomx Therapeutics Inc -49.76%$ -49.758 millions
Rxsight Inc -50.80%$ -50.797 millions
Lucid Diagnostics Inc -50.96%$ -50.962 millions
Charles River Laboratories International inc -51.61%$ -51.609 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com